Professional Documents
Culture Documents
Ibc1 000260 01 PDF
Ibc1 000260 01 PDF
Abstract
This work reports the virtual screening of several series of synthetic compounds for in silico
analysis with Insulin receptor tyrosine kinase (IRTK). It leads to the identification of
potential inhibitors of tyrosine kinase with acceptable pharmacokinetic or ADME
(Adsorption distribution metabolism and excretion) properties. Structural modification of
the library, constructed based upon heterocyclic ring and it is performed in an order with
better inhibition scores (G-Scores) and compared with already existing drugs. The
molecules with better Energy Scores were subjected to predict pharmacokinetic or ADME
properties. The ADME properties were predicted using Qikprop, Schrodinger Inc., USA.
A library of synthetic compounds was examined based on the feasibility of synthesis and in
silico screening to prioritize the molecules and to obtain potential leads as Tyrosine kinase
inhibitors.
Keywords: Insulin Receptor Tyrosine Kinase, Docking, Schrodinger, Maestro, Interactions.
1.0 Introduction
The hormone insulin stimulates the signalling intracellular pathways and it is regulating the
cellular growth and its activities. The insulin mediates by its cell surface receptor (,,,)
transmembrane glycoprotein by binding with intrinsic protein tyrosine kinase activity1. It
induces the activity at subunits. The autophosphorylation of Cytoplasmic kinase domain
promotes the cascade of signalling events with the recruitment of specific substrates like IRS1 and other phosphatidylinositol-3-kinase and glucose transporters to the cell surface. The
cytoplasmic kinase domain region of the subunit performed autophosprhorylation and also
occurs in juxtamembrane, activation loop and COOH-terminus subdomains2.
The crystallographic studies reveal that the Insulin receptor upon autophosphorylation, the
kinase A-loop undergoes a major change in conformation. During unphosphorylated state
i.e., low activity form of Insulin Receptor Kinase Domain (IRKD) with Phosphate group
which can prevent the substrate binding. The activated form of Tyr 1158, 1162 and 1163
involved in autophosphorylation and the tri-phosphorylated ATP in A-loop configuration
stabilizes and makes binding sites of cofactors and substrates. The catalytic positions are
properly placed.
1.1 Tyrosine Kinase
The developed small molecule acts by producing insulin dependent activation of Insulin
receptor tyrosine kinase domains. The small molecule has the advantages which might
resist to the physiological activity to hyperglycemia3. The large amount of receptor for
tyrosine kinase includes one and three tyrosine residues in the kinase A-loop, which involves
VII and VIII subdomains of the protein kinase catalytic core4. In the tyrosine kinase domain
other than insulin receptor can be identified, it is also depend on tyrosine autophosphorylation
in the A-loop which is Insulin like growth factor 1 (IGF-1) it is other than insulin receptor5.
2.0 Methodology
2.1 Ligand Preparation
Ligands was obtained from Interbioscreen Ltd., (IBS), Moscow, Russia, a synthetic molecule
with various functional groups. It is modified using ligprep module of the Maestro
application, Schrodinger Inc, by assigning the appropriate bond orders manually. Each
ligand was prepared manually with a full minimization with force field of the parameters
using OPLS (Optimized potential for liquid simulations)6 to eliminate bond length and angles
biased from the crystal structure. The multiple structure for each ligand were produced with
different combinations, so the protonation states i.e., ionization states were exist to involve in
any physiological condition. This operation can be performed using ionizer in Ligprep.
Ligand, functions optimally in the pH range of 7. One or more forms of different
conformations were produced to interact more strongly with the respective binding site.
Tautomeric activity was also identified for the particular inhibitor.
2.2 Macromolecular preparation
The coordinates for all the proteins obtained from Research Colloboration for Structural
Bioinformatics (RCSB, www.rcsb.org) (PDB ID 1IR3). The structure was derived from
RCSB in which all the units contain same binding site for the ligand. In the present study
has considered only one ligand. The complex was prepared by the module protein
preparation wizard, where hydrogens were added automatically and refinement of the
structure was also done. Water molecules were removed for the protein-ligand interactions
and bond orders were re-assigned. The structure was minimized to a Root mean Square
deviation of 0.30.
Ramachandran Plot Analysis
Fig. I.
The Ramachandran plot describes that most of the residues except glycine and
proline were appeared in the allowed and favorable regions.
Ramachandran Plot analysis shows that most of the residues were presented in favorable
regions and glycine and proline were presented in disallowed regions. The regions
presented in favorable regions are 93.9% and additionally allowed regions are 6.1%. It
means that, this macromolecule can be utilized for future analysis.
2.3 Ligand docking parameters
Protein and ligand were used as the initial coordinates for docking process. The docking
can be used in two approaches i.e., by having ligand as flexible and receptor is rigid or ligand
is rigid and receptor is flexible. The later approach i.e., receptor rigid option is used for the
present study, with the help of GLIDE docking approach7.
The ligand docking was performed by the receptor grid generation; for that purpose we have
used the tyrosine kinase structure complexed with peptide substrate. During the grid
generation, no vander Waals radius sampling was done and the partial charge cutoff has
been taken as 0.25 and no constraints were applied8. The location of peptide substrate has
taken as binding site for all the other ligands for docking.
3.0 Results and Discussion
3.1 Virtual Screening
After screening the library of taken natural and synthetic compounds, the score is sorted
based on High Throughput Virtual Screening (HTVS). The study shows that synthetic
compounds had better activity than the natural compound. Further the induced fit docking
study is performed for the synthetic compounds.
The GLIDE docking method is applied to various inhibitors to build an affinity model
to the insulin receptor tyrosine kinase inhibitor. The training sets of different inhibitors are
generated by scoring functions. It was characterized by orientations and Hydrogen bond
positions. According to the energy values, the synthetic molecule RBMS-01 shown better
activity with low root mean square (RMS) deviations of 0.30 . The cavity energy term is
very small; it indicates that there is a low energy penalty when the ligand is buried in the
cavity. These observations shows that inhibition of the ligand is depends on the various
conformations with the rigid type of docking. In the best docked result, the synthetic
molecule, named RBMS-01 has a best interaction with Asp, Tyr, Met, Asn of Insulin receptor
tyrosine kinase.
3. Derivatives of the parent molecule
Fig II a. RBMS-01-der-1
b. RBMS-01-der-2. The structure derived in 3rd
position of the ring. The molecule RBMS-01-der-2 shown better activity comparatively.
The compound RBMS-01 produces good docking and energy scores when compare to
other compounds. The der-2 can be derived from RBMS-01 by introducing benzene
derivative in the 3rd position. The NH group shares with the dimethyl group and another is
ketone group with heterocyclic compound. The second substituted ring shows the better
activity which displayed in Fig 2b and GLIDE score and Energy values are mentioned in
Table III.
Fig. III. Chemical structure of different kinase inhibitors in their optimized positions.
The structure were generated using Chemsketch (versions ACD Chemsketch 12.0).
The ligand docking calculations were done in the HTVS mode of GLIDE. During the
docking process the ligands are rigid and receptor treated as flexible. All the inhibitors were
passed through a scaling factor of 0.8 and partial charge cutoff of 0.15. The values were
given in Table I1,
Table II. Result of Vander Waals (Evdw), Electrostatic (Ecoul), Docking score and their energy
values after HTVS, GLIDE docking. Here, RBMS-01 shows better activity and interactions compared
with other compounds.
alterations in the receptor and it is more closely conforms and fit to the ligands. The
purpose of docking is to find the affinity between the macromolecular and ligand complex.
Further, it shows the binding between the ligands into a rigid receptor, which assumes the
correct one with low energy values. The purpose of this method is to eliminate the steric
clashes, and then the appropriate interaction will be resulted. The IFD docking was
performed from least energy after series of filtration from HTVS and standard precision using
GLIDE docking. The synthetic compound, RBMS-01 was proceeded and it recorded -44.000
Kcal as least energy. This reflects by sampling of the receptor degree of freedom and a
minimization of the receptor-inhibitor complex for many different receptor poses and it is
attempted to identify low free energy conformation of the each complex. Many researchers
demonstrated the importance of ligand binding with protein11.
3.7 ADME or pharmacokinetic predictions of the best fit molecules
The ligands with the comparable scores with other molecules were subjected to predict
pharmacokinetic properties using the QikProp module of the software. QikProp settings
determine which molecules are flagged as being dissimilar to other 95% of the known drugs.
Predicted significant ADME properties such as permeability through the predicted log IC50
value for blockage of K+ channels (QPlogHERG), QikProp predicted gut-blood barrier and
no violations of Lipinskis rule of five are reported here. The predicted property of docked
compound described in Table 4.
Table IV Information about Ligand. The drug molecule which satisfies Lipinski rule of 5,
includes molecular weight, hydrogen bond donors and acceptors.
Parent Ligand Molecule Structure
Fig IV. Structure of Ligand molecule, parent molecule structure of RBMS-01.
3.8 Ligplot Analysis
Fig V.
Protein-Ligand Interaction using Ligplot, which shows the better interaction with
Protein-Ligand Interaction
Fig VII. The representation of docked molecule between 1IR3 and ligand in wireframe
representation.
Table V The Table describes about the interactional analysis between ligand and
macromolecule where serine, glutamate shows the better activity.
In silico studies conclude that the proposed inhibitor represents a new generation of drugs for
the trea tment of Type II diabetes. Earlier studies of various drug molecules like
Acetohexamide, metformin etc. also examined, it shows that the above mentioned
compounds induces the insulin action after it binds with insulin receptor. Most of these
compounds have different molecular structures and possess specific mode of action. The
analyzed synthetic molecule which shows the better activity compared with already existing
natural drugs. Present study confirms that the natural and synthetic molecule shows the
potentiality in the hydrophobic effect based on GLIDE energy values and the followed active
sites. The proposed inhibitor which might be more effective since it simulates the residual
interaction with the respective residues like Aspartic Acid, Lysine, Methionine, Glutamic
acid and Serine also it satisfies the properties of Lipinskis rule of 5. Hence, the proposed
drug can be used for further scientific studies and to be extended to experimental validation.
Acknowledgement
I extend my sincere thanks to Dr. D. Velmurugan, HOD and Co-ordinator, Bioinformatics
Infrastructure Facility (BIF), Dept. of Biophysics, University of Madras, Guindy Campus,
Chennai, encouraged and gave me a continuous support by providing a Schrodinger software.
References
1. Ulrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, Gray A, Coussens L,
Liao YC, Tsubokawa M, Mason A, Seeburg PH, Grunfeld C, Rosen OM and Ramachandran
J.Disulfide bonds within the -subunit of insulin receptors in rat liver and brain membranes
Nature, 1985;313, 756 761 (1985).
2. White MF, Kahn CR. Cascade of autophosphorylation in the beta-subunit of the insulin
receptor. J Biol Chem 1994; 269:1-4
3.
Sportsman JR, Villar HO, Kauvar LM and Spevak WR. U.S. patent 5,851,988 (1998)
4. Hanks SK, Quinn A and Hunter T. The protein kinase family: conserved features and
deduced phylogeny of the catalytic domains. Science 1988;241:42-52.
5. Zhengwei F, Tadashi N and Hisanori Kato KV. Vitamin A Deficiency Reduces InsulinLike Growth Factor (IGF)-I Gene Expression and Increases IGF-I Receptor and Insulin
Receptor Gene Expression in Tissues of Japanese Quail (Coturnix coturnix japonica). Journal
of Nutrition. 2001;131:1189-1194
6. Jorgenson WL, Maxwell DS and Tirado-Rives J. Development and Testing of the
OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids.
J. Am. Chem. Soc., 1996;118:11225- 11236.
7. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MD,
Knoll EH, Shelly M, Perry JK, Shaw DE, Francis P and Shenkin PS. Hierarchical structurebased virtual screening for drug design J. Med. Chem., 2004;47:1739-1749.
8. Sherman W, Day T, Jacobson MP, Friesner RA, Farid R. Novel Procedure for Modeling
Ligand/Receptor Induced Fit Effects J. Med. Chem. 2006;49: 534-553.
9. Dickens M and Tavar JM. Changes in Insulin-receptor tyrosine, serine and threonine
phosphorylation as a result of substitution of tyrosine-1162 with phenylalanine Biochem. J.
1991; 274:173 - 79.
10. Taylor RD, Jewsbury PJ and Essex JW. A review of protein-small molecule docking
methods. J. Comp. Aided Mol. Des. 2002; 6:151-166.
11. Meher BR, Satish Kumar MV and Pradipta Bandyopadhyay. Molecular dynamics
simulation of HIV-protease with polarizable and non-polarizable force fields. Indian
Journal of Physics 2009;83:81-90.
List of Figures.
Ramachandran Plot Analysis
Fig I. The Ramachandran plot describes that most of the residues except glycine and proline
were appeared in the allowed and favorable regions.
Derivatives of the Parent Molecule
Fig 2 a. RBMS-01-der-1
b. RBMS-01-der-2. The structure derived in 3rd
position of the ring. The molecule RBMS-01-der-2 shown better activity comparatively.
RBMS01
RBMS02
RBMS03
RBMS04
RBMS05
RBMS06
RBMS07
RBMS08
RBMS09
RBMS10
Fig., III. Chemical structure of different kinase inhibitors in their optimized positions.
structure were generated using Chemsketch (versions ACD Chemsketch 12.0).
The
Fig V.
Protein-Ligand Interaction using Ligplot, which shows the better interaction with
Fig VI. The representation of docked molecule between 1IR3 and ligand in wireframe
representation.
Fig VII.
List of Tables.
Compound
RBMS-01-DER1
RBMS-02-DER2
HTVS
Energy
-3.88
-4.17
Gscore
-29.32
-32.91
Inhibitor
RBMS-01
RBMS-02
RBMS-03
RBMS-04
RBMS-05
RBMS-06
RBMS-07
RBMS-08
RBMS-09
RBMS-10
Evdw
-14.54
-18.27
-15.87
-13.04
-09.12
-09.86
-09.65
-09.13
-10.15
-12.82
Ecoul
-27.54
-23.78
-22.11
-37.16
-34.21
-39.55
-28.45
-24.76
-23.59
-30.65
Docking
Energy
Score
-9.40
-9.20
-9.03
-9.02
-9.02
-9.01
-8.99
-8.99
-8.94
-8.85
-42.07
-42.05
-37.99
-50.19
-43.32
-49.41
-38.10
-33.89
-33.75
-43.47
Table II. Result of Vander Waals (Evdw), Electrostatic (Ecoul), Docking score and their energy
values after HTVS, GLIDE docking. Here, RBMS-01 shows better activity and interactions compared
with other compounds.
Compounds
Voglibiose
Phenformin
Miglitol
Metformin
Tolazamide
Gliclazide
Acetohexamide
Insulin like molecule
Energy
-34.67
-19.67
-19.19
-15.78
-26.40
-26.96
-24.21
-25.67
G Score
-6.14
-5.60
-4.08
-4.79
-3.14
-2.94
-2.58
-4.97
Table III. Comparison studies with natural compounds. Results of Energy and GScore.
Among the analyzed voglibiose shown good affinity with the G-Score of -6.14 and
Acetohexamide had a G-Score of -2.58. Insulin like molecule has the G-score of -4.97, it
indicates that insulin like molecule has good affinity among the compared.
Contents
Compound Name
Values
RBMS-01
Molecular Weight
241.249
Octanol/Water
1.824
Log IC50
-3.874
Lipinskis violations
Nil
QlogP MDCK
332
Table IV Information about Ligand. The drug molecule which satisfies Lipinski rule of 5,
includes molecular weight, hydrogen bond donors and acceptors.
D .. H .. A
Dist in
G Score
1.838
2.367
2.236
1.811
1.600
1.572
-9.7387
-9.7387
-9.7387
-9.7387
-9.7387
-9.7387
Energy
Kcal
-45.47
-45.47
-45.47
-45.47
-45.47
-45.47
in
Table V The Table describes about the interactional analysis between ligand and
macromolecule where serine, glutamate shows the better activity.